VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MIRM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MIRMMirum Pharmaceuticals, Inc.
$93.72$5.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMIRMQuarterly Financials

Mirum Pharmaceuticals, Inc. (MIRM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Mirum Pharmaceuticals, Inc. (MIRM) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

MIRM Income Statement

Quarterly statement

MIRM Income Statement

Mirum Pharmaceuticals, Inc. (MIRM) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue185.72M176.24M159.88M148.93M133.01M127.78M111.58M99.41M90.38M77.88M69.22M69.55M47.73M37.5M31.6M27.91M18.78M17.48M12.89M3.14M
Revenue Growth %39.63%37.92%43.28%49.81%47.17%64.09%61.2%42.93%89.37%107.68%119.07%149.24%154.13%114.46%145.1%789.29%275.6%58.95%--
Cost of Goods Sold35.17M30.35M28.88M28.34M25.54M23.42M23.02M22.78M20.81M20.23M17.83M25.02M10.23M6.81M4.98M4.49M2.93M2.52M2.42M1.9M
COGS % of Revenue18.94%17.22%18.06%19.03%19.2%18.33%20.63%22.91%23.02%25.97%25.76%35.97%21.43%18.17%15.76%16.1%15.61%14.44%18.8%60.64%
Gross Profit150.55M145.9M131M120.59M107.47M104.36M88.57M76.63M69.57M57.65M51.39M44.53M37.5M30.68M26.62M23.41M15.85M14.96M10.47M1.24M
Gross Margin %81.06%82.78%81.94%80.97%80.8%81.67%79.37%77.09%76.98%74.03%74.24%64.03%78.57%81.83%84.24%83.9%84.39%85.56%81.2%39.36%
Gross Profit Growth %40.08%39.79%47.91%57.36%54.48%81.04%72.34%72.08%85.54%87.87%93.07%90.22%136.6%105.11%154.29%1795.71%216.96%36%--
Operating Expenses210.29M188.43M194.24M125.23M104.87M109.35M103.75M100.86M82.25M81.88M77.86M77.12M62.65M54.96M53.77M57.57M48.73M46.4M43.2M46.81M
OpEx % of Revenue113.23%106.92%121.49%84.09%78.84%85.58%92.98%101.45%91.01%105.14%112.48%110.88%131.26%146.57%170.16%206.31%259.48%265.39%335.12%1491.71%
Selling, General & Admin88.86M81.47M96.33M74.13M61.91M63.29M57.71M56.83M50.55M49.21M45.64M46.18M36.53M32.95M30.22M26.47M22.51M20.97M19.12M19.04M
SG&A % of Revenue47.85%46.23%60.25%49.77%46.55%49.53%51.71%57.16%55.93%63.19%65.93%66.4%76.54%87.87%95.64%94.85%119.88%119.93%148.28%606.6%
Research & Development107.93M90.53M97.91M51.11M42.96M46.07M46.04M44.03M31.71M32.67M32.22M30.93M26.12M22.01M23.55M31.11M26.22M25.43M24.09M27.77M
R&D % of Revenue58.11%51.37%61.24%34.32%32.3%36.05%41.26%44.29%35.09%41.95%46.55%44.48%54.72%58.7%74.52%111.46%139.6%145.46%186.84%885.12%
Other Operating Expenses1000K1000K000000000000000000
Operating Income-59.75M-42.54M-63.16M-4.57M2.6M-4.99M-15.18M-24.22M-12.68M-24.23M-26.47M-32.59M-25.15M-24.27M-27.15M-34.16M-32.88M-31.44M-32.74M-45.58M
Operating Margin %-32.17%-24.14%-39.51%-3.07%1.96%-3.9%-13.61%-24.36%-14.03%-31.12%-38.24%-46.85%-52.69%-64.73%-85.92%-122.41%-175.09%-179.83%-253.92%-1452.36%
Operating Income Growth %-2395.27%-752.62%-316.01%81.15%120.52%79.41%42.64%25.67%49.56%0.17%2.5%4.61%23.52%22.8%17.07%25.04%23.22%15.94%31.25%-23.34%
EBITDA-52.86M-35.6M-56.29M1.51M8.66M1.07M-9.13M-18.17M-6.63M-18.38M-20.8M-27.09M-22.49M-22.94M-25.81M-32.83M-31.79M-30.74M-32.29M-45.14M
EBITDA Margin %-28.46%-20.2%-35.21%1.01%6.51%0.83%-8.18%-18.27%-7.33%-23.6%-30.05%-38.95%-47.12%-61.17%-81.69%-117.65%-169.25%-175.79%-250.49%-1438.43%
EBITDA Growth %-710.01%-3436.55%-516.46%108.3%230.71%105.81%56.11%32.94%70.52%19.88%19.4%17.49%29.26%25.37%20.07%27.26%25.47%17.43%31.91%-22.7%
D&A (Non-Cash Add-back)6.89M6.94M6.87M6.07M6.06M6.06M6.05M6.06M6.05M5.85M5.66M5.49M2.66M1.34M1.34M1.33M1.1M705K443K437K
EBIT-38.62M-18.3M-786.06M-1.36M3M-1.87M-10.05M-20.79M-10.3M-20.43M-21.08M-31.87M-19.77M-70M-25.69M-31.93M-31.72M-29.62M-32.82M61.32M
Net Interest Income3.08M1.23M-215K-178K-355K-556K-573K-375K-117K-83K56K212K487K-99K-1.97M-2.22M-2.62M-3.58M-3.71M-3.7M
Interest Income4.69M3.85M3.4M3.42M3.25M3.03M3.02M3.2M3.47M3.49M3.63M3.77M4.06M3.63M2.27M2.14M1.35M293K69K65K
Interest Expense1.61M2.62M3.62M3.6M3.61M3.59M3.6M3.58M3.59M3.57M3.58M3.56M3.57M3.73M4.24M4.36M3.97M3.88M3.77M3.77M
Other Income/Expense19.52M-23M-726.52M-396K40K-470K1.53M-144K-1.2M229K1.81M-2.85M1.81M-49.45M-2.78M-2.13M-2.81M-2.05M-3.86M103.13M
Pretax Income-40.23M-65.54M-789.68M-4.96M2.64M-5.46M-13.65M-24.37M-13.89M-24M-24.66M-35.43M-23.34M-73.72M-29.93M-36.29M-35.69M-33.49M-36.59M57.56M
Pretax Margin %-21.66%-37.19%-493.91%-3.33%1.99%-4.27%-12.23%-24.51%-15.37%-30.82%-35.62%-50.94%-48.9%-196.61%-94.72%-130.05%-190.06%-191.56%-283.86%1834.23%
Income Tax538K1.69M475K767K-262K402K1.03M-576K347K635K624K225K249K316K201K140K13K-6.57M11K12K
Effective Tax Rate %-1.34%-2.58%-0.06%-15.45%-9.91%-7.36%-7.54%2.36%-2.5%-2.65%-2.53%-0.63%-1.07%-0.43%-0.67%-0.39%-0.04%19.62%-0.03%0.02%
Net Income-40.77M-67.23M-790.15M-5.73M2.9M-5.86M-14.68M-23.79M-14.23M-24.64M-25.28M-35.66M-23.59M-74.04M-30.13M-36.43M-35.71M-26.92M-36.61M57.55M
Net Margin %-21.95%-38.14%-494.21%-3.85%2.18%-4.59%-13.15%-23.93%-15.75%-31.64%-36.52%-51.27%-49.42%-197.45%-95.35%-130.55%-190.13%-153.98%-283.94%1833.84%
Net Income Growth %-1503.3%-1047.02%-5283.63%75.91%120.41%76.21%41.94%33.28%39.65%66.72%16.1%2.12%33.94%-175.01%17.69%-163.31%24.2%38.67%27.56%254.68%
Net Income (Continuing)-40.77M-67.23M-790.15M-5.73M2.9M-5.86M-14.68M-23.79M-14.23M-24.64M-25.28M-35.66M-23.59M-74.04M-30.13M-36.43M-35.71M-26.92M-36.61M57.55M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.62-1.06-13.43-0.120.05-0.12-0.30-0.49-0.30-0.52-0.54-0.71-0.57-1.94-0.80-0.97-1.02-0.84-1.171.88
EPS Growth %-1315.69%-783.33%-4376.67%75.51%117%76.92%44.44%30.99%47.37%73.2%32.5%26.8%44.12%-130.95%31.62%-151.6%34.19%42.07%30.36%231.47%
EPS (Basic)-0.62-1.06-13.43-0.120.05-0.12-0.30-0.49-0.30-0.52-0.54-0.71-0.57-1.94-0.80-0.99-1.02-0.84-1.171.88
Diluted Shares Outstanding66.05M63.37M58.85M50.2M56.99M49.73M48.89M48.34M47.78M47.24M46.93M46.72M41.1M38.11M37.68M37.52M34.93M32.18M31.3M30.58M
Basic Shares Outstanding65.53M63.37M58.85M50.2M56.99M49.73M48.89M48.34M47.78M47.24M46.93M46.72M41.1M38.11M37.68M36.96M34.93M32.16M31.3M30.32M
Dividend Payout Ratio--------------------